Literature DB >> 24452387

The potential role of rho GTPases in Alzheimer's disease pathogenesis.

Silvia Bolognin1, Erika Lorenzetto, Giovanni Diana, Mario Buffelli.   

Abstract

Alzheimer's disease (AD) is characterized by a wide loss of synapses and dendritic spines. Despite extensive efforts, the molecular mechanisms driving this detrimental alteration have not yet been determined. Among the factors potentially mediating this loss of neuronal connectivity, the contribution of Rho GTPases is of particular interest. This family of proteins is classically considered a key regulator of actin cytoskeleton remodeling and dendritic spine maintenance, but new insights into the complex dynamics of its regulation have recently determined how its signaling cascade is still largely unknown, both in physiological and pathological conditions. Here, we review the growing evidence supporting the potential involvement of Rho GTPases in spine loss, which is a unanimously recognized hallmark of early AD pathogenesis. We also discuss some new insights into Rho GTPase signaling framework that might explain several controversial results that have been published. The study of the connection between AD and Rho GTPases represents a quite unchartered avenue that holds therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452387     DOI: 10.1007/s12035-014-8637-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  171 in total

Review 1.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 3.  The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.

Authors:  John Hardy
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

Review 5.  Rho and Ras GTPases in axon growth, guidance, and branching.

Authors:  Alan Hall; Giovanna Lalli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Authors:  Robert M Koffie; Tadafumi Hashimoto; Hwan-Ching Tai; Kevin R Kay; Alberto Serrano-Pozo; Daniel Joyner; Steven Hou; Katherine J Kopeikina; Matthew P Frosch; Virginia M Lee; David M Holtzman; Bradley T Hyman; Tara L Spires-Jones
Journal:  Brain       Date:  2012-05-26       Impact factor: 13.501

Review 7.  Gene-diet interactions in brain aging and neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

Review 8.  Neuronal Rho GEFs in synaptic physiology and behavior.

Authors:  Megan B Miller; Yan Yan; Betty A Eipper; Richard E Mains
Journal:  Neuroscientist       Date:  2013-02-11       Impact factor: 7.519

9.  Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.

Authors:  Mansuo L Hayashi; Se-Young Choi; B S Shankaranarayana Rao; Hae-Yoon Jung; Hey-Kyoung Lee; Dawei Zhang; Sumantra Chattarji; Alfredo Kirkwood; Susumu Tonegawa
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

10.  Soluble aβ promotes wild-type tau pathology in vivo.

Authors:  Meredith A Chabrier; Mathew Blurton-Jones; Andranik A Agazaryan; Joy L Nerhus; Hilda Martinez-Coria; Frank M LaFerla
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

View more
  14 in total

1.  Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.

Authors:  Suho Lee; Santiago V Salazar; Timothy O Cox; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Receptor-stimulated transamidation induces activation of Rac1 and Cdc42 and the regulation of dendritic spines.

Authors:  Zhen Mi; Tuda Si; Khushboo Kapadia; Qian Li; Nancy A Muma
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

3.  Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.

Authors:  Jiao Li; Chunli Xu; Junfang Zhang; Caixia Jin; Xiujuan Shi; Chen Zhang; Song Jia; Jie Xu; Xin Gui; Libo Xing; Lixia Lu; Lei Xu
Journal:  Neurochem Res       Date:  2021-02-13       Impact factor: 3.996

4.  A direct interaction between RhoGDIα/Tau alleviates hyperphosphorylation of Tau in Alzheimer's disease and vascular dementia.

Authors:  Heping Zhang; Fan Lu; Panhong Liu; Zhaohui Qiu; Jianling Li; Xiaotong Wang; Hui Xu; Yandong Zhao; Xuemin Li; Huadong Wang; Daxiang Lu; Renbin Qi
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-26       Impact factor: 4.147

Review 5.  Delta-Catenin as a Modulator of Rho GTPases in Neurons.

Authors:  Maxsam S Donta; Yogesh Srivastava; Pierre D McCrea
Journal:  Front Cell Neurosci       Date:  2022-07-04       Impact factor: 6.147

6.  Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease.

Authors:  Mirta Borin; Claudia Saraceno; Marcella Catania; Erika Lorenzetto; Valeria Pontelli; Anna Paterlini; Silvia Fostinelli; Anna Avesani; Giuseppe Di Fede; Gianluigi Zanusso; Luisa Benussi; Giuliano Binetti; Simone Zorzan; Roberta Ghidoni; Mario Buffelli; Silvia Bolognin
Journal:  Acta Neuropathol Commun       Date:  2018-07-13       Impact factor: 7.801

7.  Effects of Amyloid Precursor Protein Overexpression on NF-κB, Rho-GTPase and Pro-Apoptosis Bcl-2 Pathways in Neuronal Cells.

Authors:  Hong Hao Chan; Yong Qi Leong; Shee Man Voon; Meng Liy Pan; Chee Onn Leong; Chooi Ling Lim; Rhun Yian Koh
Journal:  Rep Biochem Mol Biol       Date:  2021-01

8.  Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases.

Authors:  William Guiler; Addison Koehler; Christi Boykin; Qun Lu
Journal:  Front Cell Neurosci       Date:  2021-05-12       Impact factor: 5.505

9.  RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.

Authors:  Kyong Nyon Nam; Anais Mounier; Nicholas F Fitz; Cody Wolfe; Jonathan Schug; Iliya Lefterov; Radosveta Koldamova
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

Review 10.  Rho GTPases as therapeutic targets in Alzheimer's disease.

Authors:  Byron J Aguilar; Yi Zhu; Qun Lu
Journal:  Alzheimers Res Ther       Date:  2017-12-15       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.